GenSight Biologics
SIGHT.PA
#9795
Rank
NZ$55.17 M
Marketcap
$0.43
Share price
-3.82%
Change (1 day)
-40.24%
Change (1 year)

Market capitalization of GenSight Biologics (SIGHT.PA)

Market cap: NZ$55.17 Million

As of April 2025 GenSight Biologics has a market cap of NZ$55.17 Million. This makes GenSight Biologics the world's 9795th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GenSight Biologics from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$55.17 M-7.33%
2024NZ$59.53 M13.97%
2023NZ$52.23 M-80.09%
2022NZ$0.26 B-38.41%
2021NZ$0.42 B-14.27%
2020NZ$0.49 B267.1%
2019NZ$0.13 B-3.62%
2018NZ$0.14 B-44.5%
2017NZ$0.25 B-41.68%
2016NZ$0.43 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of GenSight Biologics was reported to be:

NZ$56.49 Million
by Yahoo Finance info icon info icon
NZ$56.49 Million
by CompaniesMarketCap info icon info icon